Business context and reporting period
The supplied filing is Medical Transcription Billing, Corp. (MTBC), a healthcare IT and revenue-cycle-management provider, for the quarter ended March 31, 2016. This does not match the request metadata naming CareCloud, Inc.; verify the issuer before relying on this summary.
MTBC provides practice-management software, electronic health records and billing services. It operates primarily in the United States, with significant back-office operations in Pakistan. Most revenue is tied to customer collections.
Financial performance and liquidity
| Metric | Q1 2016 | Q1 2015 / comparison |
|---|---|---|
| Revenue | $5.11 million | $6.14 million; down 17% |
| Operating loss | $1.80 million | $1.17 million |
| Net loss | $1.98 million | $1.17 million |
| Net loss attributable to common shareholders; loss per share | $2.14 million; $0.21 | $1.17 million; $0.12 |
| Adjusted EBITDA, non-GAAP | $65,000; 1.3% margin | $(710,000); (11.6%) margin |
| Cash from operations | $(404,000) | $(1.30 million) |
| Cash and current assets | $7.37 million cash; $10.37 million current assets | $8.04 million cash; $10.89 million current assets at Dec. 31, 2015 |
Operating expenses were $6.91 million, or 135.1% of revenue, versus $7.30 million, or 119.1%, a year earlier. Direct operating costs fell to $2.30 million from $3.55 million, while selling and marketing increased to $344,000 from $120,000. General and administrative expense declined 7% to $2.91 million. Depreciation and amortization totaled $1.21 million. Interest expense rose to $141,000 from $42,000.
Investing activities used $1.35 million, mainly the $1.25 million initial payment for the Gulf Coast Billing (GCB) acquisition. Financing provided $1.06 million; cash decreased by $672,000 to $7.37 million. The company reported $14.08 million of total liabilities and $12.82 million of shareholders’ equity at March 31. Opus Bank facilities totaling $10 million were fully drawn: $8 million in term loans and a $2 million revolving line. The term loans mature in 2019; monthly principal payments begin October 2016. MTBC reported compliance with the loan covenants.
Material changes versus the prior comparable period
- Revenue declined $1.03 million, primarily because revenue from customers acquired in 2014 fell by $1.8 million; revenue from the 2015 acquisitions and a revenue-share arrangement partly offset the decline.
- GAAP net loss widened, although operating cash use improved. The prior-year quarter included a much larger noncash gain from contingent consideration, affecting the comparison.
- MTBC acquired substantially all assets of GCB in February for preliminary consideration of $1.68 million: $1.25 million cash and $430,000 contingent consideration. GCB contributed approximately $376,000 of quarterly revenue.
- Stock-based compensation increased to $489,000 from $127,000. The company repurchased 518,295 shares for $427,000 during the quarter.
- Platforms customers generated about 79% of revenue, up from 71%. The company reported approximately 2,000 providers and 800 practices served, compared with 1,965 providers and 910 practices a year earlier.
Outlook, risks, contingencies and unusual items
Management gave no quantified revenue or earnings guidance. It forecast a return to profitability and said cash, preferred-stock proceeds and bank financing should cover anticipated requirements for at least 12 months. It also cautioned that continued operating losses could require additional capital or further cost reductions; financing may not be available on acceptable terms. All Opus borrowing capacity was used.
Key risks include customer retention and migration of acquired customers, integration and acquisition execution, competition, dependence on Pakistan operations, foreign-exchange and political risks, healthcare regulation, data privacy, and access to capital. The company held approximately $741,000 in Pakistani rupees at a bank without deposit insurance. Its Poland office was not sized to serve as a full backup facility.
Management concluded disclosure controls were not effective as of March 31, 2016. A previously disclosed material weakness involving complex transactions and the financial reporting and closing process had not yet been confirmed remediated; the company was testing remediation measures, including use of Oracle E-Business and an independent tax consultant.
Other notable items: preferred stock carries an 11% cumulative dividend, with $159,000 declared and paid in the quarter; common-stock dividends are prohibited without lender consent. A $1 million repurchase authorization remained active. Subsequent to quarter-end, MTBC repurchased another 126,270 shares for $119,000 and acquired Renaissance Medical Billing assets for $175,000 upfront plus revenue-based payments. Management said ordinary-course legal proceedings were not expected to have a material adverse effect.
Important facts for investors to verify
- Confirm issuer identity: the filing names Medical Transcription Billing, Corp. (MTBC), not CareCloud, Inc.
- Assess the causes and sustainability of the revenue decline, especially performance and retention of acquired customers.
- Review cash-burn trends, remaining liquidity, debt repayment requirements and compliance with Opus covenants.
- Evaluate the quality of the non-GAAP adjusted EBITDA improvement and the effects of stock compensation, acquisition costs and contingent-consideration adjustments.
- Track remediation and independent testing of the disclosed material weakness in internal controls.
- Review the GCB and subsequent Renaissance acquisition economics, including future revenue-share payments and integration results.